These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 7280609

  • 21. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C.
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [Abstract] [Full Text] [Related]

  • 22. Metolazone, a diuretic agent.
    Stern A.
    Am Heart J; 1976 Feb; 91(2):262-3. PubMed ID: 1246936
    [No Abstract] [Full Text] [Related]

  • 23. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT, Shear L.
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract] [Full Text] [Related]

  • 24. Effect of metolazone addition on furosemide resistant cases of edema.
    Kshirsagar NA, Gupta KC, Paul T, Shah BP, Vora KK, Sanghvi B, Acharya VN, Mehta JM, Sheth UK.
    J Assoc Physicians India; 1978 Oct; 26(10):915-23. PubMed ID: 750570
    [No Abstract] [Full Text] [Related]

  • 25. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
    Paton RR, Kane RE.
    J Clin Pharmacol; 1977 Apr; 17(4):243-51. PubMed ID: 849998
    [Abstract] [Full Text] [Related]

  • 26. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S, Di Pasquale P, Parrinello G, Fornaciari E, Di Gaudio F, Fasullo S, Giammanco M, Sarullo FM, Licata G.
    J Am Coll Cardiol; 2005 Jun 21; 45(12):1997-2003. PubMed ID: 15963399
    [Abstract] [Full Text] [Related]

  • 27. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK.
    Nephrology (Carlton); 2008 Jun 21; 13(3):247-50. PubMed ID: 18315706
    [Abstract] [Full Text] [Related]

  • 28. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS, Park GT, Kim YH, Shim SG, Kim JB, Lee OY, Choi HS, Hahm JS, Lee MH.
    Taehan Kan Hakhoe Chi; 2003 Dec 21; 9(4):324-31. PubMed ID: 14695699
    [Abstract] [Full Text] [Related]

  • 29. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK, da Silva JH, Kuhl DR.
    Ann Pharmacother; 2004 Apr 21; 38(4):544-9. PubMed ID: 14982985
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE, Jiang A, Devabhakthuni S, Ivaturi V, Liu T, Reed BN.
    Pharmacotherapy; 2016 Aug 21; 36(8):852-60. PubMed ID: 27393709
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Short-term course of corticosteroids in the treatment of resistant ascites complicating schistosomal liver disease.
    el-Zayadi A, Mohran Z, Hasseeb N, Nagy N, Dabbous H.
    Am J Gastroenterol; 1991 Jan 21; 86(1):53-6. PubMed ID: 1986555
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov 21; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 35. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
    Gheorghiade M, Niazi I, Ouyang J, Czerwiec F, Kambayashi J, Zampino M, Orlandi C, Tolvaptan Investigators.
    Circulation; 2003 Jun 03; 107(21):2690-6. PubMed ID: 12742979
    [Abstract] [Full Text] [Related]

  • 36. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE, Sørensen AM, Petersen JS, Andreasen F, Christensen S.
    Hepatology; 2000 Jun 03; 31(6):1224-30. PubMed ID: 10827146
    [Abstract] [Full Text] [Related]

  • 37. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V, Zjacic-Rotkvic V, Marout J, Sefer S, Troskot B.
    Croat Med J; 2003 Apr 03; 44(2):178-86. PubMed ID: 12698509
    [Abstract] [Full Text] [Related]

  • 38. [Synergistic effect of furosemide and metolazone in edema cases difficult to handle].
    Jacobson S, Berglund J, Lins LE.
    Lakartidningen; 1987 Mar 11; 84(11):846. PubMed ID: 3561104
    [No Abstract] [Full Text] [Related]

  • 39. Diuretics in malignant effusions and edemas of generalized cancer.
    Razis DV, Athanasiou A, Dadiotis L.
    J Med; 1976 Mar 11; 7(6):449-61. PubMed ID: 1070516
    [Abstract] [Full Text] [Related]

  • 40. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.
    Medcalf JF, Harris KP, Walls J.
    Kidney Int; 2001 Mar 11; 59(3):1128-33. PubMed ID: 11231370
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.